BMRN Biomarin Pharmaceutical Inc
Pharmaceutical Preparations · Nasdaq · SEC EDGAR official
Market Value*
$6.70B
Revenue (FY)
$3.22B 2025-12-31
Net Income (FY)
$348.90M
P/E (float-based)
19.2
American company.
Pharmaceutical Preparations · Nasdaq · SEC EDGAR official
American company.